X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Featured Events

Technology and Innovation drives the success of Medical Fair Asia & Medical Manufacturing Asia 2018

Content Team by Content Team
11th September 2018
in Featured Events, Press Statements

The two synergistic trade exhibitions for the medical, healthcare and MedTech sectors, MEDICAL FAIR ASIA and MEDICAL MANUFACTURING ASIA 2018 closed to resounding success on 31st August. With its largest edition to date, more than 14,000 trade visitors from 72 countries visited the fairgrounds of MEDICAL FAIR ASIA this year a 16 per cent increase from 2016. MEDICAL MANUFACTURING ASIA 2018 registered some 6,000 visitors from 56 countries – making it a 12 per cent increase from the previous edition.

The three-day synergistic exhibitions hosted more than 1,220 exhibitors from 62 countries who reached out to a diverse, international profile of visitors. While 40 percent of the visitors came from outside Singapore, the majority were from Asia with neighbouring ASEAN countries particularly well represented. As Dr Chew Wei Lun, a certified functional medicine practitioner and first-time visitor observed, “I was impressed by the breadth of products on show and the wide internationality of exhibitors. In fact, I even learned more about the rehabilitative products which I was on the lookout for.”

Confirming its position as the region’s leading business platform for the healthcare and medical sector, MEDICAL FAIR ASIA 2018 hosted a total of 23 national pavilions and country groups — its strongest line-up yet. Exhibiting under the Russian Pavilion was the Shvabe Group, which specialises in the manufacture of optical and medical equipment. According to its Managing Director and Chairman, John T.C. McGough, they were very pleased with their participation, having made many useful contacts with potential distributors. He said, “Asia is the future, and this is where growth will be in the next decade. Singapore — with its strategic locale — is the gateway to the region, and we will definitely be back in 2020 with a bigger booth.” The Russian Pavilion was among the nine new country pavilions which made their debut at MEDICAL FAIR ASIA.

MFA 2018

Future-ready solutions a big hit at the exhibitions
The positive market outlook for the medical and MedTech sectors was well-reflected by the number of high-quality visitors seeking cutting-edge solutions among the more than 10,000 products showcased at the exhibition, representing the entire end-to-end value chain from medical manufacturing processes and machinery, to finished products and components.

FREE Bionics Group’s Head of Business Development, Ms Huang Tinlan, commented that the new zone on Community Care was the perfect spot for their first time participation at MEDICAL FAIR ASIA; “Through this exhibition, we made new contacts, including doctors and therapists from rehabilitation centres as well as neurological departments from Mount Elizabeth Hospital, Tan Tock Seng and Sengkang General Hospitals. The event was a good platform to present our products and we will definitely be back in 2020.”

New technology and digital health solutions were the big draws at the exhibitions, with the new Start-up Park gaining much interest as a dedicated showcase for young companies to pitch to top decision makers and seek potential investors. For healthcare and pharmaceuticals venture capitalist Dr Anand Govindaluri, Founder and Managing Director of Govin Capital Pte Ltd, the Start-Up Park was a great place to listen to product pitches on new innovations and digital health solutions in a face-to-face setting. “This is my first visit to MEDICAL FAIR ASIA and I am particularly impressed by the Start-Up Park concept, and Future for Health (FTR4H) digital health lounge,” he said.

“With an ageing population, it is important to create a connected healthcare ecosystem, and I was excited to extend my discussions with JAGA-ME,” added Dr Govindaluri. JAGA-ME, a home-grown mobile app that aims to connect nurses and patients, was one of eight start-up companies that exhibited at MEDICAL FAIR ASIA.
On the MEDICAL MANUFACTURING ASIA front, companies with new approaches to innovation also took centre stage, underlined by the opening speech by Dr Koh Poh Koon, Senior Minister of State for Trade and Industry. He emphasised the growing trend of medical technology companies moving up the value chain and the need for new approaches and greater collaboration.

For MedTech exhibitor AMT Pte Ltd, efforts to expand their business in the medical space has increased over the last five years with their newest endeavour focused on clean room capabilities. A long-time exhibitor since MEDICAL MANUFACTURING ASIA’s first edition in 2012, AMT’s Marketing Director, Mr Zulkefli Zainal said, “The exhibition has been improving over the years and visitor traffic is much better now than before with even more quality visitors who are knowledgeable in the products on the show floor.” AMT’s manufacturing expertise includes the development and patented manufacture of metal/ceramic parts using their trademarked and award-winning “In-Coring” process which can now be used in the medical field.

The place to do business for the medical and healthcare, and MedTech sectors
Strengthening their positions as the sourcing and procurement platforms of choice, both exhibitions welcomed visiting delegations and VIP buyers from Malaysia, Indonesia, Thailand, and Vietnam. According to Dr Prapa Wongphaet, Director, S. Medical Enterprise Co Ltd, who led the Thai Medical and Wellness Tourism Association delegation, seeing the isolation tank from a UK-based company was unexpected; “This is the first time we have seen something like this, and it is exactly what we need. We can now use this tank to isolate patients in case of an epidemic. Visiting the exhibition with my team also fostered many on the spot idea generation and exchange sessions, and I am glad to bring these best practices back to our hospital,” she said.

Reiterating MEDICAL FAIR ASIA’s anchor as the medical business exhibition for the region was Mr Christophe Marque, Chairman of the Association of Malaysian Medical Industries. “The exhibition was vibrant with a lot of interaction seen between exhibitors and visitors on the show floors. It is trade exhibitions like these that value-add the industry as they pave the way for people to meet and discuss business.”

MFA 2018

For Swiss machining solutions manufacturer Willemin-Macodel SA, MEDICAL MANUFACTURING ASIA proved to be the ideal gateway to introduce and promote their manufacturing solutions to the Southeast Asian market. “Although this is our first time here, the response has been very good and we have been busy with many requests looking for medical manufacturing solutions in Malaysia, Indonesia and even high-precision manufacturing parts from Singapore,” said Mr Philippe Zürcher, Head of Business Development.

Well-attended concurrent programmes augmented the exhibitions
Complementing MEDICAL FAIR ASIA and MEDICAL MANUFACTURING ASIA 2018 were a series of industry-focused conferences, seminars and workshops covering a wide-range of topics such as Sports Medicine, Wearable Technologies, Robotic Surgery, Community Care and MedTech that attracted 700 international attendees.

According to seminar attendee Mr Dennis Ng, Executive Director of Ignite-Growth, the discussions on bringing healthcare to the community at the Paradigm Shifts in Healthcare seminar reflected “the way the world is moving towards, and (he is) happy to gain new insights for (his management consulting) company.” The seminar which made its debut at the exhibitions this year featured speakers from the Singapore General Hospital and KK Women’s and Children’s Hospital.

MEDICAL FAIR ASIA and MEDICAL MANUFACTURING ASIA are synergistic trade exhibitions for the medical, healthcare and MedTech sectors and are part of the MEDICAlliance’s network of trade fairs — sharing the global expertise of MEDICA, REHACARE, and COMPAMED — by the Messe Düsseldorf Group.
The next editions of the co-located exhibitions will take place from 9 to 11 September 2020 at the Marina Bay Sands, Singapore.

About the Organiser
Messe Düsseldorf Asia is a subsidiary (http://mda.messe-dusseldorf.com) of Messe Düsseldorf in Germany, one of the world’s leading trade fair organisers, responsible for organising more than 20 global No.1 exhibitions in various industries. With extensive expertise in organising trade fairs in Southeast Asia, Messe Düsseldorf Asia has developed a portfolio of numerous trade fairs in Southeast Asia since 1995.

Previous Post

EC approves new easy-to-use, once-weekly Bydureon BCise device for patients with type-2 diabetes

Next Post

New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute

Related Posts

ACHEMA 2022 addresses the industry's key issues digitalisation and sustainability
Manufacturing

ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability

14th June 2022
development of new antibiotics
Drug Development

EMA guidance supports development of new antibiotics

30th May 2022
Vienna Airport and Lufthansa Cargo launch pharma cooperation
Packaging & Logistic

Vienna Airport and Lufthansa Cargo launch pharma cooperation

10th May 2022
Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
Drug Development

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

6th May 2022
Catalent Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, North Carolina, Facility
Press Statements

Catalent Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, North Carolina, Facility

6th May 2022
AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint
Drug Development

AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

6th May 2022
Next Post

New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute

Latest News

Dupixent From Sanofi Delivers Another Fantastic Performance
Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

5th July 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

Singapore Authorises New Ovarian Cancer Treatment By GSK

5th July 2022
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
Manufacturing

Abbott India Affirms That The Medicines Are Not Their Own

5th July 2022
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Manufacturing

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

4th July 2022
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
Manufacturing

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

4th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In